Amir Mehdi Ansari
Internal Medicine · Baltimore, MDNPI 1174056063
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.1% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,422, more than ten times the $70 reported in 2023.
Across 62 payments — averaging $37.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biocon Biologics Inc$448
- Johnson & Johnson$348
- AstraZeneca$164
- Incyte Corporation$146
- Seagen Inc.$90
- Exelixis Inc.$72
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,16592%
- Education$1868%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biocon Biologics Inc | 2 | $448 |
| Johnson & Johnson | 10 | $348 |
| AstraZeneca(2 entities) | 3 | $164 |
| Incyte Corporation | 3 | $146 |
| Seagen Inc. | 1 | $90 |
| Exelixis Inc. | 2 | $72 |
| Puma Biotechnology, Inc. | 1 | $71 |
| GSK | 2 | $66 |
| Jazz Pharmaceuticals Inc. | 2 | $59 |
| Merck | 2 | $55 |
| Pfizer | 2 | $51 |
| Tersera Therapeutics LLC | 2 | $49 |
| AbbVie | 2 | $44 |
| Gilead | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Azurity Pharmaceuticals, Inc. | 2 | $42 |
| Mirati Therapeutics, Inc. | 2 | $41 |
| Iovance Biotherapeutics, Inc. | 1 | $38 |
| Acrotech Biopharma Inc. | 2 | $36 |
| Fresenius Kabi USA, LLC | 1 | $33 |
| Lilly USA, LLC | 1 | $33 |
| Springworks Therapeutics, Inc. | 1 | $33 |
| Pharmaessentia USA Corporation | 1 | $33 |
| Coherus Oncology, Inc. | 1 | $30 |
| Novocure Inc. | 1 | $28 |
| Beigene USA, Inc. | 1 | $27 |
| Sobi, Inc | 1 | $26 |
| Melinta Therapeutics, LLC | 1 | $26 |
| AVEO Pharmaceuticals, Inc. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Deciphera Pharmaceuticals Inc. | 1 | $24 |
| Rigel Pharmaceuticals, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $21 |
| Novartis | 1 | $20 |
| ADC Therapeutics America, Inc. | 1 | $18 |
| Caris MPI, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,350 in reported general payments places this provider in the 80th percentile of 2,979 internal medicine providers in Maryland.
Other internal medicine in Baltimore
- Param DedhiaBaltimore$636K
- Shawn DhillonBaltimore$227K
- Jeremy SugarmanBaltimore$210K
- Charles FlexnerBaltimore$133K
- Kristen MarroneBaltimore$97K
- Ana-Maria OrbaiBaltimore$89K
- Mark YarchoanBaltimore$89K
- David Muniz PedrogoBaltimore$82K
- Julie PaikBaltimore$76K
- Allison AgwuBaltimore$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.